BIOCONNSEBIOCON LIMITED.· PharmaceuticalsCriticalNegative
Announced Tue, 28 Jul · 12:31 IST

Mylan Inc sells 5.64% stake in Biocon via open market

Fii Holding DeclinedOwnership Changes View source PDF

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Mylan Inc, a US-based shareholder of Biocon Limited, sold 9,19,67,019 equity shares equal to 5.64% of Biocon equity share capital through open market on 14 July 2026. Mylan is not part of the promoter group. The disclosure was filed under SEBI Takeover Regulations 2011.

Likely market impact

Major foreign shareholder exiting a large 5.64% block via open market. May weigh on the stock in the short term.